EDITORIAL
Published on 11 Dec 2023
Editorial: Community series in novel biomarkers for predicting response to cancer immunotherapy: volume II
doi 10.3389/fimmu.2023.1328299
- 441 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy, volume II
Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy, volume II
22k
Total downloads
65k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
STUDY PROTOCOL
Published on 31 Oct 2023
Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study)
doi 10.3389/fimmu.2023.1232858
- 1,427 views
- 2 citations
ORIGINAL RESEARCH
Published on 18 Sep 2023
Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer
doi 10.3389/fimmu.2023.1086479
- 1,639 views
CLINICAL TRIAL
Published on 07 Sep 2023
Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy
doi 10.3389/fimmu.2023.1228907
- 1,512 views
- 2 citations
ORIGINAL RESEARCH
Published on 05 Jun 2023
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
doi 10.3389/fimmu.2023.1150985
- 3,031 views
- 7 citations
HYPOTHESIS AND THEORY
Published on 25 May 2023
What makes TMB an ambivalent biomarker for immunotherapy? A subtle mismatch between the sample-based design of variant callers and real clinical cohort
doi 10.3389/fimmu.2023.1151224
- 1,082 views
- 2 citations
REVIEW
Published on 22 May 2023
Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors
doi 10.3389/fimmu.2023.1171649
- 3,990 views
- 12 citations
ORIGINAL RESEARCH
Published on 19 May 2023
Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma
doi 10.3389/fimmu.2023.1169256
- 2,845 views
- 4 citations
REVIEW
Published on 21 Apr 2023
Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
doi 10.3389/fimmu.2023.1114041
- 2,584 views
- 1 citation
ORIGINAL RESEARCH
Published on 11 Apr 2023
Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer
doi 10.3389/fimmu.2023.1081790
- 2,573 views
- 8 citations
ORIGINAL RESEARCH
Published on 03 Apr 2023
Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC
doi 10.3389/fimmu.2023.1166052
- 3,577 views
- 3 citations
ORIGINAL RESEARCH
Published on 03 Apr 2023
Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma
doi 10.3389/fimmu.2023.1148483
- 2,502 views
- 5 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 65kTopic views
- 40kArticle views
- 22kArticle downloads